Subject: : To obtain clinical insights and understanding place of Tofacitnib in Rheumatoid arthritis management

Objective:: The objective of this survey is to obtain clinical insights to understand the need gap and place of Tofacitinib in the management of rheumatoid arthritis.

Tofashine contains Tofacitnib 5mg used in management of Rheumatoid arthritis, Ankylosing spondylitis and other rheumatological conditions. It is also available as 11mg extended release formulation as Tofashine XR.

Although every new product is marketed only after regulatory approval, Tofacitnib is a newer class of drug, and hence understanding its placement and usage in management of Rheumatoid arthritis is important

We invite you to participate in this survey and share your experience on performance of Tofashine. All you need to do is respond to the attached questionnaire & mention your experience with Tofacitnib in your practise.

We are partners in promoting safe and effective drug therapy, in that spirit we hope you will give consent to participate in the study. If you do, please sign and return the enclosed consent form along with your visiting card for accuracy of records